Decreased Serum Hepatocyte Growth Factor (HGF) in Individuals with Anxiety Increases After Zinc Therapy

Decreased Serum Hepatocyte Growth Factor (HGF) in Individuals with Anxiety Increases After Zinc Therapy

Show other versions (1)

Bibliographic Details
Main Author:	A.J. Russo
Format:	Article
Language:	English
Published:	SAGE Publishing 2010-08-01
Series:	Nutrition and Metabolic Insights
Online Access:	http://www.la-press.com/decreased-serum-hepatocyte-growth-factor-hgf-in-individuals-with-anxie-a2213

Similar Items

Decreased Serum Hepatocyte Growth Factor (HGF) in Individuals with Anxiety Increases after Zinc Therapy
by: A.J. Russo
Published: (2010-01-01)

Decreased Serum Hepatocyte Growth Factor (HGF) in Individuals with Bipolar Disorder Normalizes after Zinc and Anti-oxidant Therapy
by: A.J. Russo
Published: (2010-10-01)

Decreased Serum Hepatocyte Growth Factor (HGF) in Individuals with Bipolar Disorder Normalizes after Zinc and Anti-oxidant Therapy
by: A.J. Russo
Published: (2010-01-01)

Decreased Serum Hepatocyte Growth Factor (HGF) in Individuals with Depression Correlates with Severity of Disease
by: A.J. Russo
Published: (2010-08-01)

Decreased Serum Hepatocyte Growth Factor (HGF) in Individuals with Depression Correlates with Severity of Disease
by: A.J. Russo
Published: (2010-01-01)

Decreased Serum Hepatocyte Growth Factor (HGF) in Autistic Children with severe Gastrointestinal Disease
by: A.J. Russo, et al.
Published: (2009-01-01)

Decreased Zinc and Increased Copper in Individuals with Anxiety
by: A.J. Russo
Published: (2011-02-01)

Decreased Zinc and Increased Copper in Individuals with Anxiety
by: A.J. Russo
Published: (2011-01-01)

Decreased Hepatocyte Growth Factor (HGF) and Gamma Aminobutyric Acid (GABA) in Individuals with Obsessive-Compulsive Disorder (OCD)
by: Anthony J. Russo, et al.
Published: (2013-01-01)

Decreased Hepatocyte Growth Factor (HGF) and Gamma Aminobutyric Acid (GABA) in Individuals with Obsessive-Compulsive Disorder (OCD)
by: Anthony J. Russo, et al.
Published: (2013-08-01)

Increased Serum Cu/Zn SOD in Individuals with Clinical Depression Normalizes after Zinc and Anti-oxidant Therapy
by: A.J. Russo
Published: (2010-01-01)

Increased Serum Cu/Zn SOD in Individuals with Clinical Depression Normalizes After Zinc and Anti-oxidant Therapy
by: A.J. Russo
Published: (2010-06-01)

Increased Epidermal Growth Factor Receptor (EGFR) Associated with Hepatocyte Growth Factor (HGF) and Symptom Severity in Children with Autism Spectrum Disorders (ASDs)
by: Anthony J. Russo
Published: (2014-01-01)

The Role of Hepatocyte Growth Factor (HGF) in Insulin Resistance and Diabetes
by: Alexandre G. Oliveira, et al.
Published: (2018-08-01)

Correlation Between Hepatocyte Growth Factor (HGF) and Gamma-Aminobutyric Acid (GABA) Plasma Levels in Autistic Children
by: Anthony J. Russo
Published: (2013-06-01)

Correlation between Hepatocyte Growth Factor (HGF) and Gamma-Aminobutyric Acid (GABA) Plasma Levels in Autistic Children
by: Anthony J. Russo
Published: (2013-01-01)

Therapeutic role of human hepatocyte growth factor (HGF) in treating hair loss
by: Yonghao Qi, et al.
Published: (2016-11-01)

Hepatocyte growth factor (HGF) in fecal samples: rapid detection by surface plasmon resonance
by: Lundström Ingemar, et al.
Published: (2005-04-01)

MET exon 14 skipping mutation is a hepatocyte growth factor (HGF)‐dependent oncogenic driver in vitro and in humanised HGF knock‐in mice
by: Marie Fernandes, et al.
Published: (2023-11-01)

The Hepatocyte Growth Factor (HGF)/Met Axis: A Neglected Target in the Treatment of Chronic Myeloproliferative Neoplasms?
by: Marjorie Boissinot, et al.
Published: (2014-08-01)

Analysis of Plasma Zinc and Copper Concentration, and Perceived Symptoms, in Individuals with Depression, Post Zinc and Anti-Oxidant Therapy
by: A.J. Russo
Published: (2011-01-01)

Human hepatocyte growth factor (hHGF)-modified hepatic oval cells improve liver transplant survival.
by: Zhu Li, et al.
Published: (2012-01-01)

Mesenchymal stem cells microvesicles stabilize endothelial barrier function partly mediated by hepatocyte growth factor (HGF)
by: Hualing Wang, et al.
Published: (2017-09-01)

T160‐phosphorylated CDK2 defines threshold for HGF‐dependent proliferation in primary hepatocytes
by: Stephanie Mueller, et al.
Published: (2015-03-01)

Hepatocyte growth factor (HGF): a predictor of outcome and response to therapy in hepatitis C? Factor de crecimiento hepatocitario (HGF): ¿predictor de evolución y de respuesta al tratamiento de la hepatitis C?
by: F. García-Pajares, et al.
Published: (2010-06-01)

Efficacy of nonviral gene transfer of human hepatocyte growth factor (HGF) against ischemic-reperfusion nerve injury in rats.
by: Toyokazu Tsuchihara, et al.
Published: (2020-01-01)

Serum estradiol levels decrease after oophorectomy in transmasculine individuals on testosterone therapy
by: Sahil Kumar, et al.
Published: (2023-01-01)

Progranulin A Promotes Compensatory Hepatocyte Proliferation via HGF/c-Met Signaling after Partial Hepatectomy in Zebrafish
by: Keng-Yu Chiang, et al.
Published: (2021-10-01)

Partial-hepatectomized (70%) Model Shows a Correlation between Hepatocyte Growth Factor (HGF) Levels and Beta-cell Mass
by: Tiago Gomes Araujo, et al.
Published: (2015-02-01)

Hepatocyte growth factor (HGF) inhibits collagen I and IV synthesis in hepatic stellate cells by miRNA-29 induction.
by: Monika Kwiecinski, et al.
Published: (2011-01-01)

Decreased Serum Cu/Zn SOD in Children with Autism
by: A.J. Russo
Published: (2010-01-01)

Increased Copper in Individuals with Autism Normalizes Post Zinc Therapy More Efficiently in Individuals with Concurrent GI Disease
by: Anthony J. Russo
Published: (2011-01-01)

Increased Copper in Individuals with Autism Normalizes Post Zinc Therapy More Efficiently in Individuals with Concurrent GI Disease
by: Anthony J. Russo
Published: (2011-09-01)

Decreased serum Ou/Zn sOD in children with Autism
by: A.J. Russo
Published: (2009-01-01)

Circulating hepatocyte growth factor (HGF) in patients with comorbidity of chronic heart failure, type 2 diabetes mellitus and impaired lipid metabolism
by: Tatiana Nikolaevna Kochegura, et al.
Published: (2013-06-01)

A Potential Mechanism of Tumor Progression during Systemic Infections Via the Hepatocyte Growth Factor (HGF)/c-Met Signaling Pathway
by: Hironori Tsujimoto, et al.
Published: (2020-07-01)

Correlation between Hepatocyte Growth Factor (HGF) with D-Dimer and Interleukin-6 as Prognostic Markers of Coagulation and Inflammation in Long COVID-19 Survivors
by: Bena Zaira, et al.
Published: (2023-07-01)

Analysis of Copper and Zinc Plasma Concentration and the Efficacy of Zinc Therapy in Individuals with Asperger's Syndrome, Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) and Autism
by: A.J. Russo, et al.
Published: (2011-01-01)

Analysis of Copper and Zinc Plasma Concentration and the Efficacy of Zinc Therapy in Individuals with Asperger's Syndrome, Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) and Autism
by: A.J. Russo, et al.
Published: (2011-11-01)

Detection of hepatocyte growth factor (HGF) ligand-c-MET receptor activation in formalin-fixed paraffin embedded specimens by a novel proximity assay.
by: Rajiv Dua, et al.
Published: (2011-01-01)